Taken together, these results show that the expression of ELAVL2 is negatively correlated with that of EMT-related molecules at both mRNA and protein levels, suggesting that the loss of ELAVL2 may promote glioma progression by facilitating MES transition. This evidence concerns the gene ELAVL2 and central nervous system cancer.